Literature DB >> 2508736

Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy.

C C Zielinski1, C Müller, E Tichatschek, P Aiginger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2508736      PMCID： PMC2247293          DOI： 10.1038/bjc.1989.345

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  13 in total

1.  The effect of 6-mercaptopurine on primary and secondary immune responses.

Authors:  R SCHWARTZ; A EISNER; W DAMESHEK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

Review 2.  Selective suppression of humoral immunity by antineoplastic drugs.

Authors:  G H Heppner; P Calabresi
Journal:  Annu Rev Pharmacol Toxicol       Date:  1976       Impact factor: 13.820

Review 3.  The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses.

Authors:  W C Greene; W J Leonard; J M Depper; D L Nelson; T A Waldmann
Journal:  Ann Intern Med       Date:  1986-10       Impact factor: 25.391

4.  Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer.

Authors:  E Tichatschek; C C Zielinski; C Müller; P Sevelda; E Kubista; K Czerwenka; J Spona; H Wolf; M M Eibl
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Natural killer activity in peripheral lymphocyte population following local radiation therapy.

Authors:  H Blomgren; E Baral; F Edsmyr; L E Strender; B Petrini; J Wasserman
Journal:  Acta Radiol Oncol       Date:  1980

6.  The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.

Authors:  G Bonadonna; A Rossi; P Valagussa; A Banfi; U Veronesi
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

Review 7.  The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease.

Authors:  J Harris; D Sengar; T Stewart; D Hyslop
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

8.  Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer.

Authors:  S Levy; R Herberman; M Lippman; T d'Angelo
Journal:  J Clin Oncol       Date:  1987-03       Impact factor: 44.544

9.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

10.  The interleukin 2 receptor. Functional consequences of its bimolecular structure.

Authors:  H M Wang; K A Smith
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307
View more
  3 in total

1.  Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies.

Authors:  G Mantovani; A Macciò; G Astara; L Contini; S Esu; S Littera; V Arangino; P Lai; E Proto; G Pusceddu
Journal:  Cell Biophys       Date:  1993 Jan-Jun

2.  Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.

Authors:  C Wiltschke; M Krainer; A C Budinsky; A Berger; C Müller; R Zeillinger; P Speiser; E Kubista; M Eibl; C C Zielinski
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

3.  Biological significance of soluble IL-2 receptor.

Authors:  C Caruso; G Candore; D Cigna; A T Colucci; M A Modica
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.